IL6 and osteosarcoma: Likewise, tumor-activated mesenchymal stromal cells promote osteosarcoma stemness and migratory potential via IL-6 secretion 42, and si-IL-6 reduces the self-renewal (sphere formation) of the CD133+ population among non-small cell lung cancer cells.